MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Orthofix Medical Market Cap 2011-2026 | OFIX
As of April 30, 2026 Orthofix Medical has a market cap of $ 459 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Orthofix Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 491 M | 669 M | 476 M | 397 M | 612 M | 828 M | 841 M | 979 M | 1.04 B | 639 M | 742 M | 563 M | 388 M | 721 M | 726 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.04 B | 388 M | 674 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B |  USA |
 |
AdaptHealth Corp.
AHCO
|
1.2 B | $ 12.86 | -1.72 % | $ 1.74 B | USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
Electromed
ELMD
|
175 M | $ 25.1 | -0.59 % | $ 212 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
EDAP TMS S.A.
EDAP
|
139 M | $ 3.36 | 1.46 % | $ 126 M |  France |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
316 M | $ 10.57 | 2.2 % | $ 299 M | USA |
 |
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
34.8 M | $ 0.63 | -1.29 % | $ 39.2 M | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
Helius Medical Technologies
HSDT
|
3.54 M | $ 2.0 | 1.01 % | $ 1.22 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
IRIDEX Corporation
IRIX
|
16.6 M | $ 1.09 | 5.9 % | $ 18.5 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
17 M | - | - | $ 10.2 M | USA |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
437 M | $ 14.76 | 0.82 % | $ 346 M | USA |
 |
Butterfly Network
BFLY
|
766 M | $ 4.28 | -13.01 % | $ 906 M | USA |
 |
Second Sight Medical Products
EYES
|
225 M | - | -0.97 % | $ 54.4 M | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
LivaNova PLC
LIVN
|
3.81 B | $ 58.53 | -0.66 % | $ 3.19 B |  Britain |
 |
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
12.5 B | $ 88.23 | 0.49 % | $ 11.9 B | USA |
 |
Delcath Systems
DCTH
|
326 M | $ 10.25 | 0.39 % | $ 367 M | USA |
 |
Insulet Corporation
PODD
|
18.1 B | $ 169.75 | 6.08 % | $ 11.9 B | USA |
 |
CONMED Corporation
CNMD
|
1.32 B | $ 38.59 | 7.31 % | $ 1.2 B | USA |
 |
Inspire Medical Systems
INSP
|
1.76 B | $ 53.41 | - | $ 1.57 B | USA |
 |
Sintx Technologies
SINT
|
6.91 M | $ 2.0 | 0.5 % | $ 5.55 M | USA |
 |
Integer Holdings Corporation
ITGR
|
2.98 B | $ 83.01 | -0.79 % | $ 2.88 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
48.8 B | $ 80.96 | -0.32 % | $ 47.3 B | USA |
 |
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | USA |
 |
Stryker Corporation
SYK
|
147 B | $ 314.5 | -0.2 % | $ 120 B | USA |
 |
Tactile Systems Technology
TCMD
|
640 M | $ 22.53 | 0.13 % | $ 515 M | USA |
 |
TELA Bio
TELA
|
32.4 M | $ 0.84 | -1.79 % | $ 39.4 M | USA |
 |
TransMedics Group
TMDX
|
4.69 B | $ 98.83 | 0.26 % | $ 3.36 B | USA |
 |
Tandem Diabetes Care
TNDM
|
1.26 B | $ 18.77 | 3.33 % | $ 1.28 B | USA |
 |
LENSAR
LNSR
|
71.3 M | $ 5.38 | -0.19 % | $ 64.3 M | USA |
 |
Pulmonx Corporation
LUNG
|
72.8 M | $ 1.25 | 4.17 % | $ 50.9 M | USA |